Our results are concordant with those of Laviolette et al., who employed yet another transgenic model of ovarian cancer (tgCAG-LS-Tag mice) to show that estrogen promoted tumor development and progression while P4 had no impact [38]. The gene discussed is LIAS; the disease is ovarian cancer.